Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patients by Xiaopeng Sun, Margaret L. Axelrod, Adrienne G. Waks, Jingxin Fu, Molly DiLullo, Eliezer M. Van Allen, Sara M. Tolaney, Elizabeth A. Mittendorf, Yaomin Xu, Justin M. Balko

Get full text

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ov... by Sara M Tolaney, Tianyu Li, Elizabeth A Mittendorf, Geoffrey I Shapiro, Stephanie K Dougan, Nabihah Tayob, Joyce F Liu, Khanh Do, Heather Parsons, Molly DiLullo, Eileen Wrabel, Lestat R Ali, Ana C Garrido-Castro, Noah Graham, Christina Herold, Jennifer Desrosiers, Shom Goel, Amy J Williams

Get full text

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) by Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, Sangeetha M. Reddy, Leisha A. Emens, Thomas M. Kuntz, Carolina Alves Costa Silva, Saud H. AlDubayan, Hoyin Chu, Beth Overmoyer, Paulina Lange, Molly K. DiLullo, Meagan Montesion, Julie Kasparian, Melissa E. Hughes, Victoria Attaya, Ameer Basta, Nancy U. Lin, Nabihah Tayob, Rinath Jeselsohn, Elizabeth A. Mittendorf, Sara M. Tolaney

Get full text

The impact of breast radiotherapy on the tumor genome and immune ecosystem by Aislyn Schalck, Tuan Tran, Jianzhuo Li, Emi Sei, Shanshan Bai, Min Hu, Jerome Lin, Scott J. Bright, Samuel Reddick, Fei Yang, Harsh Batra, Alejandro Contreras, Maria Gabriela Raso, Michael C. Stauder, Karen E. Hoffman, Jay P. Reddy, Kevin T. Nead, Benjamin D. Smith, Gabriel O. Sawakuchi, Wendy A. Woodward, Stephanie S. Watowich, Jennifer K. Litton, Isabelle Bedrosian, Elizabeth A. Mittendorf, Huong Le-Petross, Nicholas E. Navin, Simona F. Shaitelman

Get full text